NCT01387191View on ClinicalTrials.gov

Drug Use Investigation for FLOLAN (Epoprostenol) Injection 0.5mg・1.5mg

CompletedOBSERVATIONAL
Enrollment

748

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Cardiovascular Disease
Interventions
DRUG

Epoprostenol

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY